Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.01.2024 | Case report

Carboplatin/durvalumab/etoposide

Neutropenia, anaemia and gastrointestinal bleeding

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ushijima F, et al. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review. International Cancer Conference Journal : no pagination, Jan 2023. Available from: URL: https://dx.doi.org/10.1007/s13691-023-00640-8 [Summarized from abstract] Ushijima F, et al. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review. International Cancer Conference Journal : no pagination, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1007/​s13691-023-00640-8 [Summarized from abstract]
Metadaten
Titel
Carboplatin/durvalumab/etoposide
Neutropenia, anaemia and gastrointestinal bleeding
Publikationsdatum
01.01.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52400-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Propylthiouracil

Case report

Nivolumab

Case report

Multiple drugs

Case report

Letrozole